Therapeutic effect of integrative traditional Chinese and western medicine on 51 SARS patients and its influence on their T lymphocyte subsets
Back to article page
OriginalPaper|Updated:2021-08-27
|
Therapeutic effect of integrative traditional Chinese and western medicine on 51 SARS patients and its influence on their T lymphocyte subsets
Therapeutic effect of integrative traditional Chinese and western medicine on 51 SARS patients and its influence on their T lymphocyte subsets
中国结合医学杂志(英文版)2003年9卷第4期 页码:263-265
Affiliations:
Beijing Youan Hospital,Beijing
Author bio:
Funds:
This study was supported by the Item of Special Scientific and Technological Action in Preventing and Treating SARS funded by State Administration of TCM (No. 2003AA20810)
Xiu-hui, L., Jian-hua, H., Ke, Z. et al. Therapeutic effect of integrative traditional Chinese and western medicine on 51 SARS patients and its influence on their T lymphocyte subsets., Chin. J. Integr. Med. 9, 263–265 (2003). https://doi.org/10.1007/BF02838611
Li Xiu-hui, Hu Jian-hua, Zhang Ke, et al. Therapeutic effect of integrative traditional Chinese and western medicine on 51 SARS patients and its influence on their T lymphocyte subsets[J]. Chinese Journal of Integrative Medicine, 2003,9(4):263-265.
Xiu-hui, L., Jian-hua, H., Ke, Z. et al. Therapeutic effect of integrative traditional Chinese and western medicine on 51 SARS patients and its influence on their T lymphocyte subsets., Chin. J. Integr. Med. 9, 263–265 (2003). https://doi.org/10.1007/BF02838611DOI:
Li Xiu-hui, Hu Jian-hua, Zhang Ke, et al. Therapeutic effect of integrative traditional Chinese and western medicine on 51 SARS patients and its influence on their T lymphocyte subsets[J]. Chinese Journal of Integrative Medicine, 2003,9(4):263-265. DOI: 10.1007/BF02838611.
Therapeutic effect of integrative traditional Chinese and western medicine on 51 SARS patients and its influence on their T lymphocyte subsets
摘要
Objective: To observe the clinical effect of integrative Chinese and western medicine (IC-WM) in treatment of patients with severe acute respiratory syndrome (SARS) and its influence on their T-lymphocyte subsets.Methods: Fifty-one patients with SARS of severe type were observed with synchronous non-randomized controlled method. They were divided into the ICWM group (29 patients) and the western medicine (WM) group (22 patients). Western medical treatment was applied to both groups
but to the ICWM group
Chinese medicine was given additionally. The therapeutic course was 2–3 weeks for both groups. Clinical effect and changes of T-lymphocyte subsets (CD4+) after treatment were observed.Results: In the ICWM group
26 patients (89. 66%) were cured and 3 (10. 34%) died
while in the WM group
12 (54. 55%) cured and 10 (45. 45%) died
thus comparison of the cure rate between the two groups showing significant difference (P <0.01). The score of clinical symptoms in the ICWM group was decreased from 7.14±5.20 scores before treatment to 1.82±3.75 scores after treatment
while in the WM group
it lowered from 7. 36±3.84 scores before treatment to517±417 scores after treatment
significant difference shown in the comparison of the values between the two groups after treatment (P < 0.01). Immunological function test showed that CD4+ T-lymphocyte in the ICWM group rose from 361 ± 278 cells/mm3 before treatment to 630 ± 454 cells/mm3 after treatment
showing significant difference (P < 001); but in the WM group
it merely rose from 288±186 cells/mm3 to 376±285 cells/mm3 in the corresponding period (P > 0.05).Conclusion: ICWM could improve the clinical symptoms of SARS patients markedly
enhance their T-lymphocyte immune function
and reduce their mortality.
Abstract
Objective: To observe the clinical effect of integrative Chinese and western medicine (IC-WM) in treatment of patients with severe acute respiratory syndrome (SARS) and its influence on their T-lymphocyte subsets.Methods: Fifty-one patients with SARS of severe type were observed with synchronous non-randomized controlled method. They were divided into the ICWM group (29 patients) and the western medicine (WM) group (22 patients). Western medical treatment was applied to both groups
but to the ICWM group
Chinese medicine was given additionally. The therapeutic course was 2–3 weeks for both groups. Clinical effect and changes of T-lymphocyte subsets (CD4+) after treatment were observed.Results: In the ICWM group
26 patients (89. 66%) were cured and 3 (10. 34%) died
while in the WM group
12 (54. 55%) cured and 10 (45. 45%) died
thus comparison of the cure rate between the two groups showing significant difference (P <0.01). The score of clinical symptoms in the ICWM group was decreased from 7.14±5.20 scores before treatment to 1.82±3.75 scores after treatment
while in the WM group
it lowered from 7. 36±3.84 scores before treatment to517±417 scores after treatment
significant difference shown in the comparison of the values between the two groups after treatment (P < 0.01). Immunological function test showed that CD4+ T-lymphocyte in the ICWM group rose from 361 ± 278 cells/mm3 before treatment to 630 ± 454 cells/mm3 after treatment
showing significant difference (P < 001); but in the WM group
it merely rose from 288±186 cells/mm3 to 376±285 cells/mm3 in the corresponding period (P > 0.05).Conclusion: ICWM could improve the clinical symptoms of SARS patients markedly
enhance their T-lymphocyte immune function
and reduce their mortality.
关键词
integrative Chinese and western medicineSevere Acute Respiratory SyndromeT-lymphocyte subsetstreatment
Keywords
integrative Chinese and western medicineSevere Acute Respiratory SyndromeT-lymphocyte subsetstreatment
references
ZHU YY, CAI BQ. Diagnosis and treatment of severe acute respiratory syndrome. Beijing: People’s Health Publishing Press, 2003: 209–210.
Research Group of Clinical Information, China Academy of TCM. Technical protocol for prevention and treatment of severe acute respiratory syndrome by TCM. Information on Clinical Research of Treatment of SARS by Integrative Chinese and Western Medicine (Part 2).
LI TS, QIU ZF, HAN Y, et al. Preliminary study on pathogenesis of SARS. China Medical Tribune—Progress of Study on SARS (1st Collection). 2003: 40 –42.
LI XH, ZHANG K, HU JH, et al. Clinical observation on therapeutic effect of integrative Chinese and western medicine in treating SARS. CJIM(Chin) 2003; 23(7): 489–491.
ZHAO CH, GUO YB, WU H, et al. Analysis of clinical characteristics, therapeutic effect and outcome of 108 SARS patients in Beijing. CMJ 2003; 83(11): 897–901.
Drosten C, Cunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;(10): 1967–1976.
Ksiazek TG, Erdman D, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;(10): 1953–1966.
Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome. N Engl J Med 2003; (10): 1995–2005.